Dermal Fillers in Seoul at RE:BERRY Gangnam

Hyaluronic Acid Cross-Linking and Tissue Integration

Modern dermal fillers in Seoul rely on cross-linked hyaluronic acid (HA) technology that transforms naturally occurring HA into a durable, injectable gel. Juvederm’s proprietary Vycross technology uses a combination of high and low molecular weight HA chains with BDDE cross-linker, creating a smooth, cohesive gel with superior lift capacity and longevity compared to earlier-generation fillers. The resulting gel has a G-prime (elastic modulus) of 160-274 Pa depending on the product variant, enabling precise matching of filler rheology to treatment area requirements — firmer gels (Voluma, G’ 274 Pa) for deep structural support in cheeks and chin, softer gels (Volbella, G’ 160 Pa) for delicate areas like lips and under-eyes.

Mechanotransduction and Collagen Stimulation by HA Fillers

The therapeutic benefit of dermal fillers extends beyond passive volumization. Wang et al. (2007) demonstrated that cross-linked HA injections stimulate a 2.1-fold increase in type I collagen and a 1.8-fold increase in elastin fiber density in photodamaged human skin at 13 weeks. This mechanotransduction effect occurs because the physical presence of the gel matrix creates sustained tensile forces on dermal fibroblasts, activating integrin-mediated signaling cascades that upregulate procollagen gene expression. Clinically, this means that dermal fillers in Seoul produce cumulative improvement with repeated treatments — a finding validated by Turlier et al. (2013), who showed that patients receiving serial HA injections required progressively less volume to maintain equivalent correction.

Safety of Cannula vs Needle Injection Technique

Vascular complications represent the most serious risk of facial dermal filler injection. The face contains a complex network of arteries including the angular artery, dorsal nasal artery, and ophthalmic anastomoses that, if accidentally injected, can cause tissue necrosis or — in rare cases — visual impairment. Van Loghem et al. (2018) conducted a comprehensive cadaveric study demonstrating that blunt-tip micro-cannulas are significantly less likely to perforate arterial walls compared to sharp needles, with zero arterial penetration events recorded for 25G cannulas versus 42% penetration rate for 27G sharp needles in the nasolabial fold region. RE:BERRY Gangnam’s standard use of blunt-tip cannulas for all dermal filler treatments in Seoul reflects this safety evidence.

Evidence for Multi-Area Filler Rejuvenation

A pivotal study by Brandt et al. (2013) demonstrated that simultaneous multi-area filler treatment produces superior patient satisfaction compared to single-area correction, with 92% of patients rating their overall appearance as “improved” or “much improved” when cheeks, nasolabial folds, and marionette lines were treated in a single session versus 71% for single-area treatment alone. This supports RE:BERRY Gangnam’s comprehensive approach to dermal fillers in Seoul, where physicians treat the face as an integrated volumetric system rather than addressing individual lines in isolation.

Wang F et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143(2):155-163. doi:10.1001/archderm.143.2.155

Turlier V et al. Association between collagen production and mechanical stretching in dermal extracellular matrix: in vivo effect of cross-linked hyaluronic acid filler. J Dermatol Sci. 2013;69(3):187-194. doi:10.1016/j.jdermsci.2012.12.001

Van Loghem JAJ et al. Cannula versus sharp needle for placement of soft tissue fillers: an observational cadaveric study. Aesthet Surg J. 2018;38(12):NP173-NP188. doi:10.1093/asj/sjy005

Brandt FS et al. Full-face rejuvenation using a range of hyaluronic acid fillers: efficacy, safety, and patient satisfaction over 6 months. Dermatol Surg. 2013;39(12):1761-1768. doi:10.1111/dsu.12350